HKD 2.65
(-0.38%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 17.34 Million CNY | -87.31% |
2022 | 329.43 Million CNY | 87.06% |
2021 | 176.11 Million CNY | 453.19% |
2020 | 31.83 Million CNY | -37.49% |
2019 | 50.92 Million CNY | -57.69% |
2018 | 120.35 Million CNY | -8.47% |
2017 | 134.39 Million CNY | 198.71% |
2016 | 44.01 Million CNY | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q2 | 60.47 Million CNY | 0.0% |
2023 Q4 | -24.54 Million CNY | 0.0% |
2023 FY | - CNY | -87.31% |
2023 Q2 | 41.89 Million CNY | 0.0% |
2022 Q4 | 106.67 Million CNY | 0.0% |
2022 FY | - CNY | 87.06% |
2022 Q2 | 222.75 Million CNY | 0.0% |
2021 Q2 | 56.04 Million CNY | 0.0% |
2021 Q4 | 120.07 Million CNY | 0.0% |
2021 FY | - CNY | 453.19% |
2020 Q2 | 21.26 Million CNY | 0.0% |
2020 Q4 | 10.57 Million CNY | 0.0% |
2020 FY | - CNY | -37.49% |
2019 Q4 | 23.87 Million CNY | 0.0% |
2019 FY | - CNY | -57.69% |
2019 Q2 | 27.05 Million CNY | 0.0% |
2018 Q2 | 82.41 Million CNY | 0.0% |
2018 FY | - CNY | -8.47% |
2018 Q4 | 40.88 Million CNY | 0.0% |
2017 Q2 | 30.01 Million CNY | 0.0% |
2017 Q4 | 29.54 Million CNY | 0.0% |
2017 FY | - CNY | 198.71% |
2017 Q1 | 30.01 Million CNY | 0.0% |
2016 FY | - CNY | 0.0% |
2016 Q4 | 30.01 Million CNY | 0.0% |
2016 Q2 | 10.61 Million CNY | 0.0% |
2016 Q1 | 10.61 Million CNY | 0.0% |
2015 Q4 | 10.61 Million CNY | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Wai Chun Bio-Technology Limited | 14.89 Million HKD | -16.464% |
Lee & Man Chemical Company Limited | 597.01 Million HKD | 97.095% |